Home › Research › Topics › tau-mediated-neurodegeneration
tau-mediated-neurodegeneration
3 studies tagged tau-mediated-neurodegeneration, dated 2015-05-01 to 2022-01-01. Bibliography: BibTeX (.bib) · RIS (.ris)
Newest in this topic
- Alzheimer's Disease and other Tauopathies: Exploring Efficacy of Medicinal Plant-derived Compounds in Alleviating Tau-mediated Neurodegeneration 2022-01-01
- PERK inhibition prevents tau-mediated neurodegeneration in a mouse model of frontotemporal dementia 2015-10-08
- Pulse pressure in relation to tau-mediated neurodegeneration, cerebral amyloidosis, and progression to dementia in very old adults 2015-05-01
Studies
3 studies carry this tag.
Date range
2015 to 2022
Top journals
- Acta neuropathologica 1
- Current molecular pharmacology 1
- JAMA neurology 1
Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.
-
Alzheimer's disease (AD), a major form of dementia, has been reported to affect more than 50 million people worldwide.
-
43/100
The PERK-eIF2α branch of the Unfolded Protein Response (UPR) mediates the transient shutdown of translation in response to rising levels of misfolded proteins in the endoplasmic reticulum.
-
Pulse pressure, an index of vascular aging, was associated with neurodegenerative change prior to the onset of dementia across a broad age range.